---
figid: PMC9044757__13045_2022_1263_Fig3_HTML
figtitle: 'Targeting nucleotide metabolism: a promising approach to enhance cancer
  immunotherapy'
organisms:
- Lacticaseibacillus casei
- Lactobacillus johnsonii
- Bifidobacterium pseudolongum
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Saccharomyces cerevisiae
- gut metagenome
- Zika virus
- Camelus bactrianus
organisms_ner:
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
pmcid: PMC9044757
filename: 13045_2022_1263_Fig3_HTML.jpg
figlink: /pmc/articles/PMC9044757/figure/Fig3/
number: F3
caption: Therapeutic strategies to exploit the nucleotide metabolism–immunity interplay
  in the clinic. A Targeting purine or pyrimidine pathways; B blocking DNA synthesis;
  C inhibiting adenosine pathway; D fecal microbiota transplantation. CAD carbamoyl
  phosphate synthetase, aspartyl transcarbamoylase, and dihydroorotase, IMPDH inosine
  monophosphate dehydrogenase, MDSCs myeloid-derived suppressive cells, A2AR adenosine
  2A receptor, CD39 ecto-nucleoside triphosphate diphosphohydrolase-1, ASOs antisense
  oligonucleotides, CD73 ecto-5-nucleotidase
papertitle: 'Targeting nucleotide metabolism: a promising approach to enhance cancer
  immunotherapy.'
reftext: Huai-liang Wu, et al. J Hematol Oncol. 2022;15:45.
year: '2022'
doi: 10.1186/s13045-022-01263-x
journal_title: Journal of Hematology & Oncology
journal_nlm_ta: J Hematol Oncol
publisher_name: BioMed Central
keywords: ''
automl_pathway: 0.7568272
figid_alias: PMC9044757__F3
figtype: Figure
redirect_from: /figures/PMC9044757__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9044757__13045_2022_1263_Fig3_HTML.html
  '@type': Dataset
  description: Therapeutic strategies to exploit the nucleotide metabolism–immunity
    interplay in the clinic. A Targeting purine or pyrimidine pathways; B blocking
    DNA synthesis; C inhibiting adenosine pathway; D fecal microbiota transplantation.
    CAD carbamoyl phosphate synthetase, aspartyl transcarbamoylase, and dihydroorotase,
    IMPDH inosine monophosphate dehydrogenase, MDSCs myeloid-derived suppressive cells,
    A2AR adenosine 2A receptor, CD39 ecto-nucleoside triphosphate diphosphohydrolase-1,
    ASOs antisense oligonucleotides, CD73 ecto-5-nucleotidase
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ADORA2A
  - CAD
  - DFFB
  - ACOD1
  - ENTPD1
  - PDCD1
  - RPL17
  - RPL17-C18orf32
  - CD274
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - CD8A
  - CD8B
  - ATP8A2
  - IL2
  - NT5E
  - IFNK
  - IFNW1
  - IFNA1
  - IFNA2
  - IFNA4
  - IFNA5
  - IFNA6
  - IFNA7
  - IFNA8
  - IFNA10
  - IFNA13
  - IFNA14
  - IFNA16
  - IFNA17
  - IFNA21
  - IFNB1
  - Adora2a
  - Cad
  - Dffb
  - Acod1
  - Cgct
  - Entpd1
  - Pdcd1
  - Cd274
  - Il2
  - Nt5e
  - Gusb
  - cad
  - .na.character
  - Drep4
  - Ca-alpha1D
  - shg
  - ras
  - ATPsynbeta
  - Atpalpha
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - dc
---
